Model
Edge
Ultragenyx Pharmaceutical Inc.
0001653052
Filing Type
4
Filing Date
5/4/2025
Updated
5/5/25, 5:18 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership